Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with type 1 diabetes mellitus: Relation to glycaemic control and microvascular complications

Diabetic Medicine

Volumn 17, Issue 9, 2000, Pages 650-656

  Chiarelli, F ^a,d   Spagnoli, A ^b   Basciani, F ^a   Tumini, S ^a   Mezzetti, A ^a   Cipollone, F ^a   Cuccurullo, F ^a   Morgese, G ^c   Verrotti, A ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF SIENA   (Italy)

^d Policlinico   (Italy)

Author keywords

Childhood; Diabetic nephropathy; Diabetic retinopathy; Glycaemic control; Vascular endothelial growth factor

Indexed keywords

HEMOGLOBIN A1C; VASCULOTROPIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PROGNOSIS;

ADOLESCENT; ADULT; AGING; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; INFANT, NEWBORN; INSULIN; LYMPHOKINES; REFERENCE VALUES; REGRESSION ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033782589     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00350.x     Document Type: Article

References (43)

1. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
2. Vascular endothelial growth factor is a secreted angiogenic mitogen
3. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma cell line
4. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
5. Molecular and biological properties of the vascular endothelial growth factor family of proteins
6. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
7. Vascular endothelial growth factor, a cytokine modulating endothelial function in rheumatoid arthritis
8. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
9. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis
10. VEGF, flk-1, and fit-1 expression in a rat myocardial infarction model of angiogenesis
11. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart
12. Increased serum levels of vascular endothelial growth factor in Kawasaki disease
13. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor
14. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
15. Vascular endothelial growth factor and severity of non-proliferative diabetic retinopathy mediate retinal hemodynamics in vivo: A potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy
16. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
17. Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative retinopathy
18. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy
19. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts
20. Plasma concentration of immunoreactive vascular endothelial growth factor and its relation to smoking
21. Sensitive chemiluminiscence enzyme immunoassay for vascular endothelial growth factors/vascular permeability factor in human serum
22. 21) produced by Saccharomyces cerevisisae promotes both angiogenesis and vascular permeability
23. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody
24. Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease
25. Glucose and diabetic vascular disease
26. Inhibition of sorbitol dehydrogenase: Effects on vascular and neural dysfunction in streptozotocin-induced diabetic rats
27. VEGF localisation in diabetic retinopathy
28. Elevated γ-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy
29. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat
30. Vascularised vitreoretinopathy: The role of growth factors
31. Advanced glycation end products increase retinal vascular endothelial growth factor expression
32. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195
33. Glomerular endothelial cells in culture express and secrete vascular endothelial growth factor
34. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
35. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium
36. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescent with type 1 diabetes mellitus
37. Serum levels of vascular endothelial growth factor in diabetic subjects: The relationship with blood pressure
38. Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
39. Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens
40. 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells
41. Regulation of vascular endothelial growth factor expression by insulin-like growth factor 1
42. Platelets: An important source of circulating vascular endothelial growth factors
43. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease